Acute Myeloid Leukemia Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Suspended
- Acute Myeloid Leukemia
- +5 more
- Liposome-encapsulated Daunorubicin-Cytarabine
- Pomalidomide
- Columbus, OhioOhio State University Comprehensive Cancer Center LAO
2021-10-14
Oct 14, 2021G
Not yet recruiting
- Acute Myeloid Leukemia
- Magrolimab
- +3 more
- (no location specified)
2021-10-04
Oct 4, 2021H
F
Recruiting
- Acute Biphenotypic Leukemia
- +9 more
- Total-Body Irradiation
- +10 more
- Tampa, Florida
- +2 more
2021-10-07
Oct 7, 2021K
Recruiting
- Advanced Malignant Neoplasm
- +5 more
- Los Angeles, California
- +17 more
2021-10-14
Oct 14, 2021Y
Terminated
- ACUTE MYELOID LEUKEMIA
- New Haven, ConnecticutYale Cancer Center/Smilow
2021-09-18
Sep 18, 2021F
Recruiting
- Acute Lymphoblastic Leukemia
- +16 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +4 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2021-10-13
Oct 13, 2021J
Recruiting
- Acute Myeloid Leukemia
- +2 more
- JNJ-74856665
- +2 more
- Birmingham, Alabama
- +24 more
2021-10-14
Oct 14, 2021E
Terminated
- Acute Myeloid Leukemia
- hematopoietic cell transplantation
- Non-Transplant treatment approach for consolidation
- Melbourne Victoria, Australia
- +47 more
2021-10-06
Oct 6, 2021L
Recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +4 more
- Lanzhou, Gansu, ChinaLong Zhao
2021-10-07
Oct 7, 2021G
Recruiting
- Acute Myeloid Leukemia
- Cyclophosphamide
- +2 more
- Stanford, California
- +2 more
2021-10-11
Oct 11, 2021V
Recruiting
- Chronic Lymphocytic Leukemia
- +11 more
- Zilovertamab vedotin
- Duarte, California
- +11 more
2021-10-12
Oct 12, 2021U
Active, not recruiting
- Acute Myeloid Leukemia
- Azacitidine and Venetoclax
- Aurora, ColoradoUniversity of Colorado Denver
2021-10-12
Oct 12, 2021U
Recruiting
- Acute Myeloid Leukemia
- Behavioral: UR-GOAL communication tool
- Rochester, New YorkUniversity of Rochester Medical Center
2021-10-04
Oct 4, 2021B
Not yet recruiting
- Acute Myeloid Leukemia
- Recurrent Acute Myeloid Leukemia
- Azacitidine
- +2 more
- Los Angeles, California
- +2 more
2021-10-11
Oct 11, 2021A
Recruiting
- AML
- +6 more
- Gilbert, Arizona
- +6 more
2021-10-11
Oct 11, 2021N
Recruiting
- Acute Myeloid Leukemia
- Cytarabine
- +2 more
- Little Rock, Arkansas
- +183 more
2021-10-09
Oct 9, 2021I
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- HLA-mismatched microtransplantation
- Marseille, Bouches Du Rhône, FranceInstitut Paoli Calmettes
2021-10-11
Oct 11, 2021A
Completed
- Acute Myeloid Leukemia
- AMV564
- AMV564 in combination with pembrolizumab
- San Francisco, California
- +9 more
2021-10-11
Oct 11, 2021T
Recruiting
- Acute Myeloid Leukemia
- +2 more
- CAHAG regimen
- Placebo regimen
- Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
2021-10-10
Oct 10, 2021T
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
- Idaho Falls, IdahoTeton Cancer Institute
2021-10-04
Oct 4, 2021M
Recruiting
- Acute Myeloid Leukemia
- Clofarabine
- +7 more
- Hershey, PennsylvaniaPenn State Cancer Institute
2021-10-04
Oct 4, 2021D
Recruiting
- Acute Myeloid Leukemia
- Boston, MassachusettsDana Farber Cancer Institute
2021-10-04
Oct 4, 2021A
Terminated
- Multiple Myeloma
- +6 more
- AMG 397
- +2 more
- Birmingham, Alabama
- +20 more
2021-10-08
Oct 8, 2021L
Recruiting
- Acute Myeloid Leukemia
- Lanzhou, Gansu, ChinaThe First Hospital of Lanzhou University
2021-10-07
Oct 7, 2021